Cancer-induced bone pain: Mechanisms and models

•Non-painful primary tumors often yield severely painful bone metastases in cancer patients.•Tumor-derived growth factors stimulate neuronal sprouting of nociceptors in the bone microenvironment.•Acid-sensing ion channels are activated by acidic tumor-induced osteolysis and local tumor acidity.•Cyto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience letters 2013-12, Vol.557, p.52-59
Hauptverfasser: Lozano-Ondoua, A.N., Symons-Liguori, A.M., Vanderah, T.W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 59
container_issue
container_start_page 52
container_title Neuroscience letters
container_volume 557
creator Lozano-Ondoua, A.N.
Symons-Liguori, A.M.
Vanderah, T.W.
description •Non-painful primary tumors often yield severely painful bone metastases in cancer patients.•Tumor-derived growth factors stimulate neuronal sprouting of nociceptors in the bone microenvironment.•Acid-sensing ion channels are activated by acidic tumor-induced osteolysis and local tumor acidity.•Cytokines and chemokines released in the bone microenvironment lead to nociceptive signaling and sensitization in bone.•Oxidative stress produces an increase in glutamate signaling in bone through a glutamate–cystine antiporter on tumor cells. Cancerous cells can originate in a number of different tissues such as prostate, breast and lung, but often go undetected and are non-painful. Many types of cancers have a propensity to metastasize to the bone microenvironment first. Tumor burden within the bone causes excruciating breakthrough pain with properties of ongoing pain that is inadequately managed with current analgesics. Part of this failure is due to the poor understanding of the etiology of cancer pain. Animal models of cancer-induced bone pain (CIBP) have revealed that the neurochemistry of cancer has features distinctive from other chronic pain states. For example, preclinical models of metastatic cancer often result in the positive modulation of neurotrophins, such as NGF and BDNF, that can lead to nociceptive sensitization. Preclinical cancer models also demonstrate nociceptive neuronal expression of acid-sensing receptors, such as ASIC1 and TRPV1, which respond to cancer-induced acidity within the bone. CIBP is correlated with a significant increase in pro-inflammatory mediators acting peripherally and centrally, contributing to neuronal hypersensitive states. Finally, cancer cells generate high levels of oxidative molecules that are thought to increase extracellular glutamate concentrations, thus activating primary afferent neurons. Knowledge of the unique neuro-molecular profile of cancer pain will ultimately lead to the development of novel and superior therapeutics for CIBP.
doi_str_mv 10.1016/j.neulet.2013.08.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1516756392</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304394013007222</els_id><sourcerecordid>1467070317</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-12d98053e095194337f0690c2dfc11ded05212dd6318813b4e2bd7d2f9bd9e3e3</originalsourceid><addsrcrecordid>eNqF0E1LxDAQgOEgiq6r_0CkRy_tziRp03gQZPELVrzoObTJFLP0Y21awX9vl1096mku78zAw9gFQoKA2WKdtDTWNCQcUCSQJwDigM0wVzxWWvFDNgMBMhZawgk7DWENACmm8pidcAkqA8hnbLEsWkt97Fs3WnJR2bUUbQrfXkfPZN-L1ocmREXroqZzVIczdlQVdaDz_Zyzt_u71-VjvHp5eFrermIrJQ4xcqdzSAWBTlFLIVQFmQbLXWURHTlI-dS4TGCeoygl8dIpxytdOk2CxJxd7e5u-u5jpDCYxgdLdV201I3BYIqZSjOh-f-pzBQoEKimVO5S23ch9FSZTe-bov8yCGaratZmp2q2qgZyM6lOa5f7D2PZkPtd-mGcgptdMAnRp6feBOtpgnW-JzsY1_m_P3wDTfKHtQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1467070317</pqid></control><display><type>article</type><title>Cancer-induced bone pain: Mechanisms and models</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lozano-Ondoua, A.N. ; Symons-Liguori, A.M. ; Vanderah, T.W.</creator><creatorcontrib>Lozano-Ondoua, A.N. ; Symons-Liguori, A.M. ; Vanderah, T.W.</creatorcontrib><description>•Non-painful primary tumors often yield severely painful bone metastases in cancer patients.•Tumor-derived growth factors stimulate neuronal sprouting of nociceptors in the bone microenvironment.•Acid-sensing ion channels are activated by acidic tumor-induced osteolysis and local tumor acidity.•Cytokines and chemokines released in the bone microenvironment lead to nociceptive signaling and sensitization in bone.•Oxidative stress produces an increase in glutamate signaling in bone through a glutamate–cystine antiporter on tumor cells. Cancerous cells can originate in a number of different tissues such as prostate, breast and lung, but often go undetected and are non-painful. Many types of cancers have a propensity to metastasize to the bone microenvironment first. Tumor burden within the bone causes excruciating breakthrough pain with properties of ongoing pain that is inadequately managed with current analgesics. Part of this failure is due to the poor understanding of the etiology of cancer pain. Animal models of cancer-induced bone pain (CIBP) have revealed that the neurochemistry of cancer has features distinctive from other chronic pain states. For example, preclinical models of metastatic cancer often result in the positive modulation of neurotrophins, such as NGF and BDNF, that can lead to nociceptive sensitization. Preclinical cancer models also demonstrate nociceptive neuronal expression of acid-sensing receptors, such as ASIC1 and TRPV1, which respond to cancer-induced acidity within the bone. CIBP is correlated with a significant increase in pro-inflammatory mediators acting peripherally and centrally, contributing to neuronal hypersensitive states. Finally, cancer cells generate high levels of oxidative molecules that are thought to increase extracellular glutamate concentrations, thus activating primary afferent neurons. Knowledge of the unique neuro-molecular profile of cancer pain will ultimately lead to the development of novel and superior therapeutics for CIBP.</description><identifier>ISSN: 0304-3940</identifier><identifier>EISSN: 1872-7972</identifier><identifier>DOI: 10.1016/j.neulet.2013.08.003</identifier><identifier>PMID: 24076008</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Acid Sensing Ion Channels - metabolism ; Animals ; ASIC ; Bone Neoplasms - complications ; Bone Neoplasms - metabolism ; Bone Neoplasms - secondary ; Cytokines ; Cytokines - metabolism ; Disease Models, Animal ; Glutamate ; Humans ; Mice ; Nerve Growth Factors - metabolism ; NGF ; Oxidative Stress ; Oxidative Stress - physiology ; Pain - etiology ; Pain - metabolism ; Rats ; Syngenic tumor model</subject><ispartof>Neuroscience letters, 2013-12, Vol.557, p.52-59</ispartof><rights>2013 Elsevier Ireland Ltd</rights><rights>Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-12d98053e095194337f0690c2dfc11ded05212dd6318813b4e2bd7d2f9bd9e3e3</citedby><cites>FETCH-LOGICAL-c441t-12d98053e095194337f0690c2dfc11ded05212dd6318813b4e2bd7d2f9bd9e3e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0304394013007222$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24076008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lozano-Ondoua, A.N.</creatorcontrib><creatorcontrib>Symons-Liguori, A.M.</creatorcontrib><creatorcontrib>Vanderah, T.W.</creatorcontrib><title>Cancer-induced bone pain: Mechanisms and models</title><title>Neuroscience letters</title><addtitle>Neurosci Lett</addtitle><description>•Non-painful primary tumors often yield severely painful bone metastases in cancer patients.•Tumor-derived growth factors stimulate neuronal sprouting of nociceptors in the bone microenvironment.•Acid-sensing ion channels are activated by acidic tumor-induced osteolysis and local tumor acidity.•Cytokines and chemokines released in the bone microenvironment lead to nociceptive signaling and sensitization in bone.•Oxidative stress produces an increase in glutamate signaling in bone through a glutamate–cystine antiporter on tumor cells. Cancerous cells can originate in a number of different tissues such as prostate, breast and lung, but often go undetected and are non-painful. Many types of cancers have a propensity to metastasize to the bone microenvironment first. Tumor burden within the bone causes excruciating breakthrough pain with properties of ongoing pain that is inadequately managed with current analgesics. Part of this failure is due to the poor understanding of the etiology of cancer pain. Animal models of cancer-induced bone pain (CIBP) have revealed that the neurochemistry of cancer has features distinctive from other chronic pain states. For example, preclinical models of metastatic cancer often result in the positive modulation of neurotrophins, such as NGF and BDNF, that can lead to nociceptive sensitization. Preclinical cancer models also demonstrate nociceptive neuronal expression of acid-sensing receptors, such as ASIC1 and TRPV1, which respond to cancer-induced acidity within the bone. CIBP is correlated with a significant increase in pro-inflammatory mediators acting peripherally and centrally, contributing to neuronal hypersensitive states. Finally, cancer cells generate high levels of oxidative molecules that are thought to increase extracellular glutamate concentrations, thus activating primary afferent neurons. Knowledge of the unique neuro-molecular profile of cancer pain will ultimately lead to the development of novel and superior therapeutics for CIBP.</description><subject>Acid Sensing Ion Channels - metabolism</subject><subject>Animals</subject><subject>ASIC</subject><subject>Bone Neoplasms - complications</subject><subject>Bone Neoplasms - metabolism</subject><subject>Bone Neoplasms - secondary</subject><subject>Cytokines</subject><subject>Cytokines - metabolism</subject><subject>Disease Models, Animal</subject><subject>Glutamate</subject><subject>Humans</subject><subject>Mice</subject><subject>Nerve Growth Factors - metabolism</subject><subject>NGF</subject><subject>Oxidative Stress</subject><subject>Oxidative Stress - physiology</subject><subject>Pain - etiology</subject><subject>Pain - metabolism</subject><subject>Rats</subject><subject>Syngenic tumor model</subject><issn>0304-3940</issn><issn>1872-7972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0E1LxDAQgOEgiq6r_0CkRy_tziRp03gQZPELVrzoObTJFLP0Y21awX9vl1096mku78zAw9gFQoKA2WKdtDTWNCQcUCSQJwDigM0wVzxWWvFDNgMBMhZawgk7DWENACmm8pidcAkqA8hnbLEsWkt97Fs3WnJR2bUUbQrfXkfPZN-L1ocmREXroqZzVIczdlQVdaDz_Zyzt_u71-VjvHp5eFrermIrJQ4xcqdzSAWBTlFLIVQFmQbLXWURHTlI-dS4TGCeoygl8dIpxytdOk2CxJxd7e5u-u5jpDCYxgdLdV201I3BYIqZSjOh-f-pzBQoEKimVO5S23ch9FSZTe-bov8yCGaratZmp2q2qgZyM6lOa5f7D2PZkPtd-mGcgptdMAnRp6feBOtpgnW-JzsY1_m_P3wDTfKHtQ</recordid><startdate>20131217</startdate><enddate>20131217</enddate><creator>Lozano-Ondoua, A.N.</creator><creator>Symons-Liguori, A.M.</creator><creator>Vanderah, T.W.</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QP</scope><scope>7TK</scope></search><sort><creationdate>20131217</creationdate><title>Cancer-induced bone pain: Mechanisms and models</title><author>Lozano-Ondoua, A.N. ; Symons-Liguori, A.M. ; Vanderah, T.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-12d98053e095194337f0690c2dfc11ded05212dd6318813b4e2bd7d2f9bd9e3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acid Sensing Ion Channels - metabolism</topic><topic>Animals</topic><topic>ASIC</topic><topic>Bone Neoplasms - complications</topic><topic>Bone Neoplasms - metabolism</topic><topic>Bone Neoplasms - secondary</topic><topic>Cytokines</topic><topic>Cytokines - metabolism</topic><topic>Disease Models, Animal</topic><topic>Glutamate</topic><topic>Humans</topic><topic>Mice</topic><topic>Nerve Growth Factors - metabolism</topic><topic>NGF</topic><topic>Oxidative Stress</topic><topic>Oxidative Stress - physiology</topic><topic>Pain - etiology</topic><topic>Pain - metabolism</topic><topic>Rats</topic><topic>Syngenic tumor model</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lozano-Ondoua, A.N.</creatorcontrib><creatorcontrib>Symons-Liguori, A.M.</creatorcontrib><creatorcontrib>Vanderah, T.W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuroscience letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lozano-Ondoua, A.N.</au><au>Symons-Liguori, A.M.</au><au>Vanderah, T.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer-induced bone pain: Mechanisms and models</atitle><jtitle>Neuroscience letters</jtitle><addtitle>Neurosci Lett</addtitle><date>2013-12-17</date><risdate>2013</risdate><volume>557</volume><spage>52</spage><epage>59</epage><pages>52-59</pages><issn>0304-3940</issn><eissn>1872-7972</eissn><abstract>•Non-painful primary tumors often yield severely painful bone metastases in cancer patients.•Tumor-derived growth factors stimulate neuronal sprouting of nociceptors in the bone microenvironment.•Acid-sensing ion channels are activated by acidic tumor-induced osteolysis and local tumor acidity.•Cytokines and chemokines released in the bone microenvironment lead to nociceptive signaling and sensitization in bone.•Oxidative stress produces an increase in glutamate signaling in bone through a glutamate–cystine antiporter on tumor cells. Cancerous cells can originate in a number of different tissues such as prostate, breast and lung, but often go undetected and are non-painful. Many types of cancers have a propensity to metastasize to the bone microenvironment first. Tumor burden within the bone causes excruciating breakthrough pain with properties of ongoing pain that is inadequately managed with current analgesics. Part of this failure is due to the poor understanding of the etiology of cancer pain. Animal models of cancer-induced bone pain (CIBP) have revealed that the neurochemistry of cancer has features distinctive from other chronic pain states. For example, preclinical models of metastatic cancer often result in the positive modulation of neurotrophins, such as NGF and BDNF, that can lead to nociceptive sensitization. Preclinical cancer models also demonstrate nociceptive neuronal expression of acid-sensing receptors, such as ASIC1 and TRPV1, which respond to cancer-induced acidity within the bone. CIBP is correlated with a significant increase in pro-inflammatory mediators acting peripherally and centrally, contributing to neuronal hypersensitive states. Finally, cancer cells generate high levels of oxidative molecules that are thought to increase extracellular glutamate concentrations, thus activating primary afferent neurons. Knowledge of the unique neuro-molecular profile of cancer pain will ultimately lead to the development of novel and superior therapeutics for CIBP.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>24076008</pmid><doi>10.1016/j.neulet.2013.08.003</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0304-3940
ispartof Neuroscience letters, 2013-12, Vol.557, p.52-59
issn 0304-3940
1872-7972
language eng
recordid cdi_proquest_miscellaneous_1516756392
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acid Sensing Ion Channels - metabolism
Animals
ASIC
Bone Neoplasms - complications
Bone Neoplasms - metabolism
Bone Neoplasms - secondary
Cytokines
Cytokines - metabolism
Disease Models, Animal
Glutamate
Humans
Mice
Nerve Growth Factors - metabolism
NGF
Oxidative Stress
Oxidative Stress - physiology
Pain - etiology
Pain - metabolism
Rats
Syngenic tumor model
title Cancer-induced bone pain: Mechanisms and models
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A10%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer-induced%20bone%20pain:%20Mechanisms%20and%20models&rft.jtitle=Neuroscience%20letters&rft.au=Lozano-Ondoua,%20A.N.&rft.date=2013-12-17&rft.volume=557&rft.spage=52&rft.epage=59&rft.pages=52-59&rft.issn=0304-3940&rft.eissn=1872-7972&rft_id=info:doi/10.1016/j.neulet.2013.08.003&rft_dat=%3Cproquest_cross%3E1467070317%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1467070317&rft_id=info:pmid/24076008&rft_els_id=S0304394013007222&rfr_iscdi=true